The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Influenza virus haemagglutinin

Australian Public Assessment Report

AusPAR

Australian Public Assessment Report for Quadrivalent Influenza Vaccine [PDF, 1.35 MB]

Australian Public Assessment Report for Quadrivalent Influenza Vaccine [Word, 1.07 MB]

AusPAR Attachment 1. Product Information for Quadrivalent Influenza Vaccine [PDF, 370.85 KB]

AusPAR Attachment 1. Product Information for Quadrivalent Influenza Vaccine [Word, 352.5 KB]

Device/Product Name

Flucelvax Quad

Active ingredients

Influenza virus haemagglutinin

AusPAR Date

17 December 2020

Published

24 December 2020

Submission Number

PM-2019-02591-1-2

Submission Type

New biological entity

Decision

Approved